Viewing StudyNCT00989586



Ignite Creation Date: 2024-05-05 @ 9:53 PM
Last Modification Date: 2024-10-26 @ 10:11 AM
Study NCT ID: NCT00989586
Status: COMPLETED
Last Update Posted: 2017-02-06
First Post: 2009-10-02

Brief Title: Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Sponsor: Beth Christian
Organization: Ohio State University Comprehensive Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-09
Start Date Type: None
Primary Completion Date: 2015-04
Primary Completion Date Type: ACTUAL
Completion Date: 2015-09
Completion Date Type: ACTUAL
First Submit Date: 2009-10-02
First Submit QC Date: October 2 2009
Study First Post Date: 2009-10-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-02-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-08
Last Update Post Date: 2017-02-06
Last Update Post Date Type: ESTIMATED